China in Africa
Thrombin loaded DNA origami fight cancer – animal experiments
CAS news release, February 13, 2018
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Window-to-China
BGI releases desktop HTP sequencer
The instrument, called Revolocity BGISEQ-500, will be delivered from February, 2017, and is one third less expensive than comparable instruments. It uses advanced combined probe anchor polymerization technology (cPAS) and DNA nanoparticles (DNB) sequencing technology. An icon touch operating system, compatible with automatic sample tracking management, provides optimized process guidance, and a card type sequencing chip integrated into the sequencing kit containing prefabricated high precision micro machining allows for 10 hours of automatic sample loading and sequencing in unattended mode. If equipped with an optional automated sample preparation system, the entire process including sample preparation is complete in 18 hrs.
China Bio news release, November 7, 2016
China Pharmaceutical Enterprise Association publishes EHS guide
The environenment, health and safety standards and guidelines” are directed towards a sustainable development of the industry and to better access to the international markets.”
China Bio news release, November 11, 2016
CAS Zhengzhou Fruit Research Institute reports genetic basis for peach aroma characteristics
The group around Lirong WANG has analaysed 12 gene regions associated with the characteristic taste and appearance of peaches, based on genome sequencing of 129 modern peach cultivars. For example, the acidity of a peach may be affected by the variation of plant hormone transporter gene expression, and the peache’s shape may be determined by the expression of apoptosis related proteins.
China Bio news release, November 11, 2016
220 varieties of traditional Chinese medicine (TCM) will be added to the Chinese Pharmaopoeia in 2020
As announced by the State Phamracopoeia Commission on its website, this will bring the total number of varieties to 6,400, of which about 220 varieties will be TCM. The safety standards of these varieties will be strongly improved (pesticide reidues, heavy metals, allergenics), and the identification of individual compounds will be further standardized.
China Bio news release, November 11, 2016
CAS Institute of Microbiology develops novel in-vitro pathogen detection system
The group of Chunbo LOU, together with the Peking iGEM team, developed a novel paired dCas9 reporter system. As a proof of concept, they successfully distinguished Mtb genome markers. The paired dCas9 reporter system is programmed by single guide RNAs complementary to the upstream and downstream segments of a target DNA sequence, respectively. When substrate DNA containing the two segment-sequences in proximity are detected and bound by a pair of dCas9, luminescence is generated from the catalytic activity of luciferase in its entirety. In this detection system, sequence information (including complementary sequence and spacer sequence) and output signal amplification are obtained simultaneously.
CAS news release, November 10, 2016
CAS led-team develops full-color 3D meta holography with single nanostructured layer
The research team, led by Xiangang Luo from the State Key Laboratory of Optical Technologies on Nano-fabrication and Micro-engineering, CAS, and Minghui Hong’s team from Department of Electrical and Computer Engineering, National University of Singapore, have demonstrated full-color 3D meta-holography imaging with extended viewing angles, realized by a single layer of nanostructured metallic surface. The usable data capacity and cross-talk limitations were improved and by using a single type of plasmonic pixel. This not only led to a remarkable image quality, with a signal-to-noise ratio (SNR) five times better than that of the previous meta-hologram designs, but to a full-color meta-holographic image in the 3D space, with pending applications in data storage, security, and authentication.
CAS news release, November 11, 2016
Researchers at CAS QIBEBT improve process for zero-discharge seawater desalination
The group of Yang ZHANG and colleagues at the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), CAS, has developed a combination of nanofiltration and electrodialysis to produce ion-free water from seawater with over 98 % water recovery.
CAS news release, November 11, 2016
Group at USTC sets world distance record of 404 km for secure quantum communication
he group of Jianwei PAN at the University of Science and Technology of China (USTC) of CAS, have sent secure quantum protocol, known as measurement-device-independent quantum key distribution (MDIQKD), over a distance of 404 km. Compared with earlier experiments, they demonstrated a 500-fold increase in speed, reaching a key-distribution rate that would be sufficient to ensure encrypted voice transmission by telephone.
CAS news release, November 11, 2016
China will boost robot development
According to Zhongxue GAN, Dean of Ningbo Institute of Intelligent Manufacturing Industries, industrial robots in China will soon be developed into two-armed robots with online-sensing intelligence and some AI during the Made in China 2025″ program. “Robots in the factories can not only serve as the operator, but as well as workshop supervisor and leaders, even the president, which means that there are robots taking the worker’s job and robots taking the management position. The workshop achieving the coordinative work of human beings and robots can be called as the real intelligent workshop”.”
CAS news release, November 9, 2016
Merck KGaA invests 250 million € in its Nantong plant.
The investment is split in 170 million € for Nantong pharmaceutical base which will focus on the production of high quality Chinese medicine. In the inauguration ceremony, Merck also announced the establishment of life science center in Nantong with an investment of 80 million euros, specializing in the production of high purity inorganic salts and cell culture medium.
China Bio news release, November 7, 2016
US Amgen opens research center in Suzhou
The center will be built with Suzhou Medical Research Institute, under the Chinese Academy of Medical Sciences, and focus on tumor immunity-related projects.
CAS news release, November 7, 2016
BGI, Intel Healthcare Asia Pacific and Alibaba sign into a trilateral strategy on an Open Cloud Platform
During the Tenth International Conference on Genomics (ICG-11) in Shenzhen, the three companies signed a strategic cooperation memorandum on the combination of cloud computing, big data and artificial intelligence within the Healthy China 2030″ program”
China Bio news release, November 4, 2016
Shenzhen’s Hong Rui Kang Biotechnology Co. launches personalized microbial skin care products
Based on individual diagnostic of the skin flora through a cotton swab-based skin analysis sent to the company and analyzed in a proprietary skin flora intervention database, the company offers skin care products which contain classical components such as skin softeners and moisturizing agents, but also GRAS microorganisms which are known to establish a healthy skin flora.
China Bio news release, November 4, 2016
China reports progress on biomass power generation
The three most important raw materials are straw (over 700 million t/year), municipal waste and livestock manure. China’s installed capacity for biomass energy power generation is second in the world: the current total installed capacity is 14,23 million kW, of which 9,5 million kW enter the grid. During 125″, agricultural mechanization, crop straw collection, bundling and transport efficiency has been greatly improved. In “135”, a focus will be on improving technologies and bringing it to the remoter parts of China.”
China Bio news release, November 11, 2016
Canada’s Global Drug Commercialization Center opens branch in Chengdu
Headquartered in Vancouver, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine. It works in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.
China Bio news release, November 2, 2016